AHSA2 (Activator of Hsp90 ATPase 2) is a member of the AHA (Activator of Hsp90 ATPase) protein family that functions as a co-chaperone for Hsp90 (Heat Shock Protein 90). Together with its close homolog AHSA1, AHSA2 stimulates the ATPase activity of Hsp90, facilitating the proper folding, maturation, and stabilization of a wide range of client proteins [1]. The Hsp90 chaperone system is essential for cellular proteostasis and is particularly important for neuronal protein quality control, making AHSA2 relevant to neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and other protein aggregation disorders [2].
The Hsp90 complex represents one of the most important systems for maintaining protein homeostasis in eukaryotic cells. Hsp90 itself has weak ATPase activity, and its functional cycle requires co-chaperones like AHSA2 to stimulate ATP hydrolysis, which drives the conformational changes necessary for client protein maturation. AHSA2 shares significant structural and functional similarity with AHSA1 but has distinct expression patterns and may have partially non-overlapping functions in certain tissues and cellular contexts [3].
Structure
AHSA2 has a characteristic AHA family structure:
Domain Architecture
N-terminal domain: ~180 amino acids, contains the Hsp90-binding region
C-terminal domain: ~150 amino acids, contains the ATPase stimulatory activity
Dimer formation: Can form homodimers that bind to Hsp90 dimers
Structural Features
Hsp90 Binding:
N-terminal domain binds to the middle domain of Hsp90
Binding stimulates conformational changes in Hsp90
Dimer interface allows simultaneous interaction with both Hsp90 protomers
Catalytic Center:
C-terminal domain contains the ATPase stimulatory activity
Critical residues for stimulation of Hsp90 ATP hydrolysis
Conserved across AHA family members
Comparison with AHSA1:
44% sequence identity with AHSA1
Similar overall fold and domain organization
Differences in surface residues may affect binding specificity
Normal Function
Hsp90 ATPase Stimulation
AHSA2 accelerates Hsp90 ATP hydrolysis approximately 10-fold [4]:
Hsp90 binding: AHSA2 binds to Hsp90 via its N-terminal domain
ATPase stimulation: C-terminal domain accelerates ATP hydrolysis
Conformational cycle: Drives the Hsp90 functional cycle
Client release: Facilitates release of properly folded client proteins
Client Protein Maturation
AHSA2, together with AHSA1 and other co-chaperones, regulates:
[Human Protein Atlas](https://www.proteinatlas.org/ENSG00000163235-AHSA2)
References
[The AHA family of Hsp90 co-chaperones (Cell Stress Chaperones, 2018)](https://pubmed.ncbi.nlm.nih.gov/29359478/)
[Hsp90 co-chaperones in neurodegeneration (Neurobiol Dis, 2020)](https://pubmed.ncbi.nlm.nih.gov/32822467/)
[Comparative analysis of AHA1 and AHA2 (J Mol Biol, 2017)](https://pubmed.ncbi.nlm.nih.gov/28919534/)
[Panaretou et al., Activation of the ATPase activity of hsp90 by the co-chaperone Cdc37 and p23 (Mol Cell, 2002)](https://pubmed.ncbi.nlm.nih.gov/11907279/)
[Chen et al., Targeting Hsp90 for Alzheimer's disease therapy (Future Med Chem, 2016)](https://pubmed.ncbi.nlm.nih.gov/26647310/)
[Luo et al., Hsp90 and cochaperones in neurodegeneration (Adv Exp Med Biol, 2020)](https://pubmed.ncbi.nlm.nih.gov/31630911/)
[Retzlaff et al., Hsp90 is regulated by a switch in its functional cycle (Nat Cell Biol, 2009)](https://pubmed.ncbi.nlm.nih.gov/19344235/)
[Targeting Hsp90 in disease (Pharmacol Ther, 2019)](https://pubmed.ncbi.nlm.nih.gov/31376876/)